Judge OKs Settlement In Drug Securities Case
A judge has given his final approval to a $52.5 million settlement agreement in two related securities cases filed against pharmaceutical company Sepracor Inc. over statements made about the antihistamine, Soltara....To view the full article, register now.
Already a subscriber? Click here to view full article